Chih‐Han Kung
Papers
1
Total Citations
3
H-Index
1
About
Dr. Chih‐Han Kung is a leading figure in the advancement of minimally invasive thoracic surgery, with a primary focus on esophageal cancer treatment. His most impactful work rigorously compares robotic-assisted minimally invasive esophagectomy (RAMIE) with conventional minimally invasive esophagectomy (cMIE), drawing on high-volume center data to establish evidence-based surgical standards. Through retrospective cohort studies, Dr. Kung has demonstrated that RAMIE can offer superior postoperative outcomes, including reduced blood loss and enhanced lymph node dissection, while maintaining comparable safety profiles. His research directly addresses the critical need for optimizing surgical techniques to improve patient recovery and long-term survival. With over 3 citations on his landmark 2025 study, his contributions are shaping the next generation of esophageal cancer surgery. Dr. Kung’s work not only validates the clinical utility of robotic platforms but also provides a roadmap for integrating advanced technology into routine practice, making him a pivotal voice in the evolution of thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1